First batch of COVID-19 vaccine reaches Srinagar

Srinagar: The first batch of COVID-19 vaccines reached Srinagar Wednesday afternoon with officials saying that the first dose will be given to health care workers.

“Today, we received our 1st batch of Covid-19 vaccine and vaccination will be started on 16 January across the country for which department has already done groundwork and mock drills,” officials said.

State Immunisation Officer Dr Qazi Haroon said that they received first batch of vaccines in Srinagar on Wednesday afternoon and accordingly they will be forwarded to different areas so that vaccination drive can begin along with other states on 16 January.

Qazi said that they have arranged choppers to take vaccines to far off places in J&K like Gurez, Tanghdar Karnah and by Friday they will be all ready to start the vaccination process along with the entire country on Saturday.

Pertinently, the first phase of the vaccination drive will cover 30 crore people in India.

India has authorised two Covid-19 vaccines – indigenous Bharat Biotech’s Covaxin and the Oxford-AstraZeneca & Serum Institute of India vaccine Covishield for emergency use.

Related Posts

Commissioner FDA reviews enforcement measures

Srinagar: Commissioner, Food & Drugs Administration (FDA), Jammu & Kashmir, Khalid Jahangir on Thursday held an introductory meeting with senior officers and field functionaries of Drug and Food Wing of the…

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court Ashwagandha ruling offers interim relief to supplement makers challenging the FSSAI advisory on Ashwagandha extracts. The Karnataka High Court has stayed an advisory issued by the Food…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Karnataka High Court stays FSSAI advisory banning use of Ashwagandha leaves in health supplements

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

Roche Pharma launches Tecentriq® SC, India’s first subcutaneous immunotherapy for lung cancer

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

CDSCO tighten drug quality oversight as substandard and spurious medicine cases rise in five years

Piramal Pharma Gets 3 USFDA Observations at US Facility

Piramal Pharma Gets 3 USFDA Observations at US Facility

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices

Eli Lilly pauses Indian obesity awareness campaign after regulatory notices